PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsRare mutation may protect against heart disease

BioNews

Rare mutation may protect against heart disease

Published 14 September 2016 posted in News and appears in BioNews 852

Author

Rachel Reeves

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A rare genetic mutation reduces the risk of having a heart attack by one-third, a study has found...

A rare genetic mutation reduces the risk of having a heart attack by one-third, a study has found.

The mutation, which substantially lowers levels of non-HDL cholesterol – a marker for heart-disease risk – is already being investigated as potential drug target for preventing heart disease.

'[This is] an important and previously unknown mechanism for modulating non-HDL cholesterol and risk of the most common and deadly forms of heart disease,' said Dr Kári Stefánsson, founder and CEO of deCODE Genetics, who led the research. 'We know we have put our finger on something fundamental when we find a single variant that confers on carriers an average one year of extra lifespan,' he added.

The study, published in the New England Journal of Medicine, matched the genomic data of around 400,000 Icelanders against their medical records. The team found that fewer than one percent of these individuals had a loss-of-function mutation that was associated with significantly lower levels of non-HDL cholesterol. Carriers of the mutation were also 34 percent less likely to develop heart disease, and lived on average one year longer. The researchers could not find any adverse effects of having this mutation.

Dr Stefánsson and his team noticed the same correlation when they looked at the genomes of over 300,000 people of European ancestry, including populations from the Netherlands, Denmark, Germany, New Zealand, the UK and the USA.

The mutation they identified was in the gene ASGR1. Although the researchers do not yet know how the mutation results in a reduction in the risk of heart disease, Amgen – the technology giant that bought deCODE Genetics in 2012 (see BioNews 686) – is already developing drugs to mimic its protective effect.

Researchers found a mutation with a similar effect over a decade ago (see BioNews 758), and Amgen recently developed a drug based on it. The drug was approved by the US Food and Drug Adminstration last year. But Dr Stefánsson believes that this new drug target may be even more effective as he says it reduces heart-disease risk by more than would be expected given its effect on cholesterol alone. 'This is a genetic discovery that is pointing to the possibility of manipulating something other than just blood lipids,' he told Nature News. 'We have no drugs, really, that affect the risk of coronary heart disease that work on alternative mechanisms.'

However, Professor Harlan Krumholz, a cardiology researcher at Yale University in Connecticut, is unconvinced by this claim. 'This study is far from identifying an alternative mechanism of risk reduction for a variant associated with non-HDL reduction,' he told Nature News.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 February 2022 • 2 minutes read

Rare genetic variants associated with cardiometabolic diseases discovered

by Joseph Hawkins

Analysis of recently released exome sequence data has identified an association between rare genetic variants and cardiometabolic diseases, such as diabetes and heart failure...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
17 April 2020 • 2 minutes read

Cancer gene helps regrow heart cells

by Dr Molly Godfrey

A gene normally associated with cancer could help to repair damaged heart tissue...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 October 2018 • 2 minutes read

£40 gene test could predict heart disease risk

by Dr Melanie Krause

A one-off genetic test could identify people with a genetic predisposition to coronary heart disease, according to a new study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 May 2017 • 2 minutes read

Birthweight linked to genes involved in adult diseases

by Meetal Solanki

Genes involved in determining a baby's birthweight may also predispose them to diseases in later life, such as heart disease and type 2 diabetes, a global study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
10 February 2017 • 2 minutes read

Over 600,000 at risk of sudden death from faulty heart gene

by Julianna Photopoulos

About 620,000 people in the UK carry a faulty heart gene that puts them at high risk of sudden death or developing coronary heart disease, the British Heart Foundation has warned...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 March 2016 • 3 minutes read

Rare mutation turns 'good' cholesterol bad

by Sophie Perry

A rare genetic mutation that causes high levels of 'good' cholesterol also appears to block its positive effects, increasing the risk of heart disease by 80 percent...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 November 2014 • 3 minutes read

Gene mutation carriers get equivalent of lifetime's anti-cholesterol treatment

by Dr Lanay Griessner

An inactive copy of a gene associated with cholesterol levels can reduce the risk of a heart attack, according to a study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 June 2014 • 2 minutes read

Four gene mutations lower heart attack risk

by Dr Charlotte Warren-Gash

Four rare gene mutations may protect against heart attacks by lowering levels of a type of fat called triglycerides, according to research in the New England Journal of Medicine.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 April 2013 • 2 minutes read

Ageing genes may affect cancer and heart risk

by Dr Greg Ball

Genes that influence the so-called 'biological age' of cells may also influence susceptibility to many age-related diseases...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 January 2013 • 2 minutes read

Gene passed from father to son added to list of heart disease risks

by Zara Mahmoud

A sixth of men have a genetic variant which could increase their risk of heart disease by up to 56 percent, according to a recent study...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« DNA damage from cannabis use can be inherited, scientists claim

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856